IQVIA (IQV) vs Mettler-Toledo International (MTD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
IQVIA (IQV) has outperformed Mettler-Toledo International (MTD) over the past year, gaining 28.5% versus a gain of 17.1%. Over five years, MTD leads with a +8.2% price change compared with +3.7% for IQV. IQVIA is the larger company by market cap ($42.48 billion vs $30.73 billion), about 1.4 times the size.
On valuation, IQVIA trades at a lower forward P/E (17.9x vs 29.6x for Mettler-Toledo International). Mettler-Toledo International converts more of its revenue into profit, with a net margin of 21.6% versus 8.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IQV | MTD |
|---|---|---|
| Share price | $258.11 | $1,533.48 |
| Market cap | $42.48B | $30.73B |
| 1-day change | -0.72% | +0.03% |
| YTD return | +14.51% | +9.99% |
| 1-year return | +28.50% | +17.14% |
| 5-year return | +3.72% | +8.16% |
| P/E ratio (TTM) | 32.06 | 34.56 |
| Forward P/E | 17.90 | 29.62 |
| EPS (TTM) | $8.05 | $44.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $16.31B | $4.03B |
| Revenue growth (YoY) | +5.87% | +3.98% |
| Net income (latest FY) | $1.36B | $869.19M |
| Gross margin | 33.29% | 59.37% |
| Operating margin | 13.38% | — |
| Net margin | 8.34% | 21.59% |
| 52-week high | $277.40 | $1,585.72 |
| 52-week low | $154.50 | $1,023.05 |
| Distance from 52-week high | -6.95% | -3.29% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +12.68% | -4.04% |
| Average volume | 1.44M | 183.40K |
| Shares outstanding | 164.60M | 20.04M |
| Employees | 94,000 | 16,600 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IQV has outperformed MTD by 11.4 percentage points over the past year.
- Mettler-Toledo International is more profitable, keeping 21.6 cents of every revenue dollar as net income versus 8.3 cents for IQVIA.
- The two companies sit in different sectors: IQVIA in Health Care and Mettler-Toledo International in Industrials.
About IQVIA
IQV stock →IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 94,000 employees
About Mettler-Toledo International
MTD stock →Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees
IQV vs MTD FAQ
Which is bigger, IQVIA or Mettler-Toledo International?
IQVIA (IQV) is larger, with a market capitalization of $42.48B compared with $30.73B for Mettler-Toledo International (MTD).
Which stock has performed better over the past year, IQV or MTD?
IQV returned +28.50% over the past 12 months, compared with +17.14% for MTD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, IQV or MTD?
IQV has the lower trailing P/E at 32.1, versus 34.6 for MTD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are IQVIA and Mettler-Toledo International in the same industry?
No. IQVIA is in the Health Care sector, while Mettler-Toledo International is in Industrials.